TNFSF13B and systemic lupus erythematosus: Belimumab is a monoclonal antibody that targets the B-lymphocyte stimulator (BLyS), a key factor in B cell survival and a contributor to the pathogenesis of systemic lupus erythematosus (SLE) [1].